Chemkart

Chemkart

206.00
-4.45
(-2.11%)
Market Cap
249.22 Cr
EPS
25.54
PE Ratio
10.49
Dividend Yield
0.00 %
Industry
-
52 Week High
262.00
52 Week Low
190.00
PB Ratio
2.16
Debt to Equity
0.36
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Chemkart India Limited submitted an investor presentation to BSE showcasing its position as a B2B supplier of raw ingredients for nutritional, sports, and health supplements. The company, established in 2015 and headquartered in Mumbai, reported strong financial performance with revenue growing from ₹131.38 crores in FY23 to ₹203.28 crores in FY25, representing a 32.7% three-year CAGR. EBITDA increased with a 67.1% CAGR and PAT showed 64.2% CAGR over the same period. The company operates with over 150 ingredients across 10+ product categories, serving 500+ clients with a 30,000 sq.ft warehouse facility in Bhiwandi. Chemkart announced construction of a greenfield nutraceutical CDMO facility through its subsidiary Easy Raw Materials at JNPT SEZ, Maharashtra, expected to be operational by FY27. The facility will focus on manufacturing, packaging, and export of health supplements with technologies like microencapsulation and liposomal delivery systems. The company maintains domestic revenue at 99.25% with minimal export presence currently.
positive
Chemkart India Limited announced that its wholly owned subsidiary Easy Raw Materials Pvt. Ltd. (EZRM) has commenced construction of a greenfield nutraceutical manufacturing facility at JNPA Special Economic Zone in Maharashtra. The facility will operate as a Contract Development and Manufacturing Organization (CDMO) focusing on formulation, packaging, and global exports of health supplements. The project represents Chemkart's strategic expansion from trading and distribution into manufacturing. The facility is being built on a 4,120 sq.m plot leased for 60 years and will incorporate advanced technologies including microencapsulation and liposomal delivery systems. Construction milestones include completed site clearance, ongoing platform excavation, and initiated pile foundation work. The SEZ location provides duty-free import-export benefits and proximity to India's largest container port for enhanced global market access.
Forecast
Actual
Growth Rate
Revenue Growth
54.74 %
Net Income Growth
67.59 %
Cash Flow Change
19,950.00 %
ROE
-9.01 %
ROCE
-11.53 %
EBITDA Margin (Avg.)
4.04 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
87
132
133
206
0
Expenses
80
120
111
171
0
EBITDA
8
11
22
35
0
Operating Profit %
8 %
8 %
16 %
16 %
0 %
Depreciation
0
0
0
1
0
Interest
0
1
1
2
0
Profit Before Tax
7
11
20
33
0
Tax
2
3
5
8
0
Net Profit
6
8
15
24
0
EPS in ₹
6.71
8.06
15.28
25.54
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
25
38
54
86
Fixed Assets
1
6
5
9
Current Assets
24
32
48
77
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
24
32
48
77
Total Liabilities
25
38
54
86
Current Liabilities
17
23
24
33
Non Current Liabilities
0
0
0
0
Total Equity
7
15
29
53
Reserve & Surplus
6
13
28
44
Share Capital
1
1
1
10

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
-0
3
Investing Activities
-1
-5
-0
-4
Operating Activities
-6
0
0
4
Financing Activities
7
5
0
3

Share Holding

% Holding
Mar 2025
Jun 2025
Jul 2025
Promoter
100.00 %
73.31 %
73.31 %
FIIs
0.00 %
1.77 %
1.77 %
DIIs
0.00 %
9.14 %
9.14 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
11.19 %
11.19 %
Others
0.00 %
4.59 %
4.59 %
No of Share Holders
7
7
7

Technical Indicators

RSI(14)
Neutral
42.19
ATR(14)
Less Volatile
9.10
STOCH(9,6)
Neutral
74.22
STOCH RSI(14)
Overbought
93.07
MACD(12,26)
Bullish
1.44
ADX(14)
Very Strong Trend
50.98
UO(9)
Bearish
52.24
ROC(12)
Uptrend And Accelerating
4.25
WillR(14)
Neutral
-33.33